2025 US-Taiwan Bioscience Forum,

About the event

Rapid advancements in gene sequencing, such as reduced costs of Next Generation Sequencing (NGS) and improved big data analysis, have boosted the feasibility and utility of precision medicine. This new medical model uses personalized care, integrated biological data and big data analytics to customize treatments for patients, improve healthcare outcome, and benefit the overall healthcare society. BIS Research reports that the global precision medicine market, valued at USD 43.59 billion in 2016, is projected to reach USD 141.7 billion by 2026 as a result of advancement in gene sequencing and bioinformatics.

​

The success of precision medicine requires interdisciplinary expertise and cross-functional collaboration. Innovations in minimally-invasive technology, AI-enhanced big data, and the use of novel biomarkers have driven the development and evolvement of personalized medicine in the last decade.

​

To gain a full picture of the industry and hear from different perspectives, this forum will feature experts from both academia and industry and across various functional areas in the broader biopharmaceutical value chain. Experts will discuss the emerging trends and challenges in precision medicine, as well as sharing their career takeaway insights to inspire the future leaders in the broader life sciences industry.

​

This forum is hosted by Bay Area Taiwanese Biotechnology Association (BATBA) with the sponsorship from National Science and Technology Council, Taiwan (NSTC).

​

Why should you sponsor?

BATBA is a non-profit organization dedicated to biotech professionals in the San Francisco Bay Area. Our goal is to provide a platform for emerging Taiwanese leaders in biotech industry to communicate scientific developments and business ideations, as well as to offer career coaching to young professionals and students. 

Our annual US–Taiwan Bioscience Forum (UTBF) —"Innovation and Development in Cross-disciplinary Precision Health"— will take place on Saturday, September 6th, 2025, at the Crowne Plaza Foster City – San Mateo.

  This year, we are honored to feature Dr. Joe Wu (Director, Stanford Cardiovascular Institute) and Dr. Gene Lay (Founder, BioLegend) as our keynote speakers. The forum will bring together leaders from academia, industry, and government to explore cross-disciplinary innovation in precision health and foster Taiwan–US biotech collaboration.
 

  We sincerely hope you will consider supporting UTBF this year. Your sponsorship will play a pivotal role in the success of our events, and we would be honored to establish a meaningful partnership with your organization. By sponsoring UTBF, you not only help bring these events to life, but also gain valuable visibility and engagement opportunities within the Bay Area's vibrant biotech community. We would be grateful for the opportunity to further discuss how we can align our goals and create mutual value through this partnership.

YunHung Tu

BATBA is a Founded 501c(3) Non-Profit Organization founded in 2018 and is one of the 10 Taiwanese Biotech Associations in the world. BATBA's mission is to foster career development and networking of the newer Taiwanese generation and to enhance communications and collaborations among the broader biotech sectors in US and Taiwan.

Contact the Organizer Contact the Organizer